RT Journal Article
SR Electronic
T1 The role of prisons in disseminating tuberculosis in Brazil: a genomic epidemiology study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.22.21259360
DO 10.1101/2021.06.22.21259360
A1 Walter, Katharine S.
A1 dos Santos, Paulo César Pereira
A1 Gonçalves, Thais Oliveira
A1 da Silva, Brunna Oliveira
A1 Santos, Andrea da Silva
A1 Leite, Alessandra de Cássia
A1 da Silva, Alessandra Moura
A1 Moreira, Flora Martinez Figueira
A1 de Oliveira, Roberto Dias
A1 Lemos, Everton Ferreira
A1 Cunha, Eunice
A1 Liu, Yiran E.
A1 Ko, Albert
A1 Colijn, Caroline
A1 Cohen, Ted
A1 Mathema, Barun
A1 Croda, Julio
A1 Andrews, Jason R.
YR 2021
UL http://medrxiv.org/content/early/2021/11/10/2021.06.22.21259360.abstract
AB Background Globally, prisons are high-incidence settings for tuberculosis. Yet the role of prisons as reservoirs of M. tuberculosis, propagating epidemics through spillover from prisons to surrounding communities, has been difficult to measure directly.Methods and Findings To quantify the role of prisons in driving wider community M. tuberculosis transmission, we conducted prospective genomic surveillance in Central West Brazil from 2014 to 2019. We whole genome sequenced 1,152 M. tuberculosis isolates collected during active and passive surveillance inside and outside prisons and linked genomes to detailed incarceration histories. We applied multiple phylogenetic and genomic clustering approaches and inferred timed transmission trees. We found that M. tuberculosis sequences from incarcerated and non-incarcerated people were closely related in a maximum likelihood phylogeny. The majority (70.8%; 46/65) of genomic clusters including people with no incarceration history also included individuals with a recent history of incarceration. Among cases in individuals with no incarceration history, 50.6% (162/320) were in clusters that included individuals with recent incarceration history, suggesting that transmission chains often span prisons and communities. We identified a minimum of 18 highly probable spillover events, M. tuberculosis transmission from people with a recent incarceration history to people with no prior history of incarceration, occurring in the state’s four largest cities and across sampling years. We additionally found that frequent transfers of people between the state’s prisons creates a highly connected prison network that likely disseminates M. tuberculosis across the state.Conclusions We developed a framework for measuring spillover from high-incidence environments to surrounding communities by integrating genomic and spatial information to reconstruct tuberculosis transmission chains. Our findings indicate that, in this setting, prisons serve not only as disease reservoirs, but also disseminate M. tuberculosis across highly connected prison networks, both amplifying and propagating M. tuberculosis risk in surrounding communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institutes of Health grant R01AI130058 (JRA) and R01 AI149620 (JRA and JC). Brazil's National Council for Scientific and Technological Development grant 404237/2012-6 (JC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written consent, and this study was conducted with the approval of the Research Ethics Committee from the Federal University of Grande Dourados, Federal University of Mato Grosso do Sul and National Research Ethics Committee (CONEP) (CAAE 37237814.4.0000.5160, 2676613.3.1001.5160, and 26620619.6.0000.0021) and Stanford University Institutional Review Board (IRB-40285).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data is available on the Sequence Read Archive (SRA), in BioProject PRJNA671770.